Credit Suisse’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | – | Sell |
-2,479,960
| Closed | -$115M | – | 3570 |
|
2019
Q2 | $115M | Buy |
2,479,960
+1,276,651
| +106% | +$59.1M | 0.1% | 156 |
|
2019
Q1 | $29.3M | Buy |
1,203,309
+862,361
| +253% | +$21M | 0.03% | 506 |
|
2018
Q4 | $4.86M | Buy |
340,948
+157,250
| +86% | +$2.24M | 0.01% | 1279 |
|
2018
Q3 | $2.79M | Sell |
183,698
-68,990
| -27% | -$1.05M | ﹤0.01% | 1738 |
|
2018
Q2 | $4.24M | Buy |
252,688
+24,439
| +11% | +$410K | ﹤0.01% | 1539 |
|
2018
Q1 | $3.73M | Buy |
228,249
+13,917
| +6% | +$227K | ﹤0.01% | 1609 |
|
2017
Q4 | $2.74M | Sell |
214,332
-24,427
| -10% | -$313K | ﹤0.01% | 1814 |
|
2017
Q3 | $2.94M | Sell |
238,759
-41,802
| -15% | -$514K | ﹤0.01% | 1841 |
|
2017
Q2 | $2.35M | Sell |
280,561
-147,473
| -34% | -$1.23M | ﹤0.01% | 1808 |
|
2017
Q1 | $3.83M | Buy |
428,034
+282,089
| +193% | +$2.52M | ﹤0.01% | 1582 |
|
2016
Q4 | $1.28M | Sell |
145,945
-17,373
| -11% | -$153K | ﹤0.01% | 2504 |
|
2016
Q3 | $1.1M | Sell |
163,318
-73,214
| -31% | -$494K | ﹤0.01% | 2557 |
|
2016
Q2 | $843K | Buy |
236,532
+10,503
| +5% | +$37.4K | ﹤0.01% | 2785 |
|
2016
Q1 | $667K | Buy |
226,029
+94,848
| +72% | +$280K | ﹤0.01% | 2746 |
|
2015
Q4 | $554K | Sell |
131,181
-857
| -0.6% | -$3.62K | ﹤0.01% | 3082 |
|
2015
Q3 | $602K | Sell |
132,038
-204,443
| -61% | -$932K | ﹤0.01% | 3071 |
|
2015
Q2 | $2.43M | Buy |
336,481
+141,580
| +73% | +$1.02M | ﹤0.01% | 2178 |
|
2015
Q1 | $1.44M | Sell |
194,901
-72,269
| -27% | -$532K | ﹤0.01% | 2449 |
|
2014
Q4 | $1.26M | Buy |
267,170
+181,330
| +211% | +$858K | ﹤0.01% | 2606 |
|
2014
Q3 | $306K | Sell |
85,840
-33,957
| -28% | -$121K | ﹤0.01% | 3540 |
|
2014
Q2 | $546K | Sell |
119,797
-26,097
| -18% | -$119K | ﹤0.01% | 3354 |
|
2014
Q1 | $686K | Sell |
145,894
-109,053
| -43% | -$513K | ﹤0.01% | 3114 |
|
2013
Q4 | $1.28M | Buy |
254,947
+147,117
| +136% | +$737K | ﹤0.01% | 2687 |
|
2013
Q3 | $671K | Buy |
107,830
+4,290
| +4% | +$26.7K | ﹤0.01% | 2886 |
|
2013
Q2 | $470K | Buy |
+103,540
| New | +$470K | ﹤0.01% | 2964 |
|